PARP1 and leiomyosarcoma: Then, we searched for research on molecular features of uLMS using the keyword “leiomyosarcoma and genomic” via PubMed as well as for ongoing clinical trials on uLMS in ClinicalTrials.gov (https://clinicaltrials.gov/ accessed on 10 November 2021) using the keywords “uterine leiomyosarcoma”, “sarcoma”, and “PARP inhibitor”.